Alnylam Pharmaceuticals
ALNY
#1123
Rank
HK$165.09 B
Marketcap
HK$1,233
Share price
3.61%
Change (1 day)
-64.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company